-
Income Statement
-
Balance Sheet
-
Cashflow Statement
-
Profitability
-
Ratios
Johnson & Johnson's Income Statement
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue |
|
$78.74 B | $79.99 B | $85.16 B | $88.82 B | $94.19 B |
| Cost of Revenue |
|
$23.40 B | $24.60 B | $26.55 B | $27.47 B | $25.64 B |
| Gross Profit |
|
$55.34 B | $55.39 B | $58.61 B | $61.35 B | $68.56 B |
| Research & Development |
|
$14.28 B | $14.14 B | $15.09 B | $17.23 B | $14.67 B |
| Selling,General & Administrative |
|
$20.12 B | $20.25 B | $20.11 B | $21.97 B | $23.68 B |
| Operating Expense |
|
$34.40 B | $34.38 B | $35.20 B | $39.20 B | $42.96 B |
| Operating Income |
|
$20.94 B | $21.01 B | $23.41 B | $22.15 B | $25.60 B |
| Net Income |
|
$20.88 B | $17.94 B | $35.15 B | $14.07 B | $26.80 B |
Johnson & Johnson's Assets vs Liabilities & Equity
Johnson & Johnson's Balance Sheet
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Cash and Cash Equivalents |
|
$31.61 B | $22.28 B | $22.93 B | $24.52 B | $20.10 B |
| Inventories |
|
$10.39 B | $10.27 B | $11.18 B | $12.44 B | $14.19 B |
| Total Current Assets |
|
$60.98 B | $55.29 B | $53.50 B | $55.89 B | $55.62 B |
| Property,Plant and Equipment |
|
$18.96 B | $17.98 B | $19.90 B | $20.52 B | $23.17 B |
| Goodwill |
|
$35.25 B | $36.05 B | $36.56 B | $44.20 B | $48.77 B |
| Total Assets |
|
$182.02 B | $187.38 B | $167.56 B | $180.10 B | $199.21 B |
| Total Liabilities |
|
$108.00 B | $110.57 B | $98.78 B | $108.61 B | $117.67 B |
| Retained Earnings |
|
$123.06 B | $128.35 B | $153.84 B | $155.79 B | $168.98 B |
| Total Shareholder Equity |
|
$74.02 B | $76.80 B | $68.77 B | $71.49 B | $81.54 B |
| Common Stock |
|
$3.12 B | $3.12 B | $3.12 B | $3.12 B | $3.12 B |
Johnson & Johnson's Cash flow
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Depreciation & Amortization |
|
$7.39 B | $6.97 B | $7.49 B | $7.34 B | $7.50 B |
| Dividends Payout |
|
-$11.03 B | -$11.68 B | -$11.77 B | -$11.82 B | -$12.38 B |
| Capital Expenditures (Capex) |
|
-$3.65 B | -$4.01 B | -$4.54 B | -$4.42 B | -$4.83 B |
| Free Cash Flow (FCF) |
|
$19.76 B | $17.19 B | $18.25 B | $19.84 B | $19.70 B |
Johnson & Johnson's Profitability
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Gross Profit |
|
$55.34 B | $55.39 B | $58.61 B | $61.35 B | $68.56 B |
| Gross Profit Margin (%) |
|
70.28% | 69.25% | 68.82% | 69.07% | 72.78% |
| Operating Income |
|
$20.94 B | $21.01 B | $23.41 B | $22.15 B | $25.60 B |
| Operating Income Margin (%) |
|
26.60% | 26.27% | 27.49% | 24.94% | 27.17% |
| Net Income |
|
$20.88 B | $17.94 B | $35.15 B | $14.07 B | $26.80 B |
| Net Income Margin (%) |
|
26.52% | 22.43% | 41.28% | 15.84% | 28.46% |
| EBITDA |
|
$26.75 B | $26.61 B | $23.32 B | $24.78 B | $32.58 B |
| EBITDA Margin (%) |
|
33.97% | 33.26% | 27.38% | 27.90% | 42.36% |
Johnson & Johnson's Ratios
| Chart | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) |
|
28.20% | 23.36% | 51.11% | 19.68% | - |
| Return on Assets (ROA) |
|
11.47% | 9.57% | 20.98% | 7.81% | - |
| Debt to Equity |
|
45.60% | 51.61% | 42.65% | 51.24% | 58.78% |
| Debt to total asset |
|
18.54% | 21.16% | 17.51% | 20.34% | 24.06% |
| Enterprise value to revenue |
|
5.96 | 6.11 | 4.75 | 4.04 | 0.00 |
| Enterprise value to EBITDA |
|
17.53 | 18.36 | 17.35 | 14.48 | 0.00 |
| Enterprise value |
|
$469.00 B | $488.44 B | $404.57 B | $358.79 B | - |
| Tax Rate (%) |
|
7.18% | 15.44% | 11.53% | 15.71% | 17.73% |
Frequently Asked Questions
